Thiol-based mucolytics exhibit antiviral activity against SARS-CoV-2 through allosteric disulfide disruption in the spike glycoprotein
Y. Shi, A. Zeida, C. E. Edwards, M. L. Mallory, S. Sastre, M. R. Machado, R. J. Pickles, L. Fu, K. Liu, J. Yang, R. S. Baric, R. C. Boucher, R. Radi, K. S. Carroll
This study shows thiol-based mucolytics inhibit SARS-CoV-2 by disrupting disulfides in the spike protein, reducing ACE2 binding and viral infection.
bioRxiv · Jul 1, 2021Microbiology